Noriko Shimazu

747 total citations
10 papers, 596 citations indexed

About

Noriko Shimazu is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Noriko Shimazu has authored 10 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Noriko Shimazu's work include Liver Disease Diagnosis and Treatment (4 papers), Immune Response and Inflammation (2 papers) and Liver physiology and pathology (2 papers). Noriko Shimazu is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Immune Response and Inflammation (2 papers) and Liver physiology and pathology (2 papers). Noriko Shimazu collaborates with scholars based in Japan and United States. Noriko Shimazu's co-authors include Yasutaka Miyachi, Shinobu Yamaguchi, Chikara Komiya, Yoshihiro Ogawa, Kumiko Shiba, Kyoichiro Tsuchiya, Kazuo Kanno, Toshiaki Katada, Kenji Kontani and Kentaro Mori and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Scientific Reports.

In The Last Decade

Noriko Shimazu

10 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noriko Shimazu Japan	8	267	241	240	144	98	10	596
A. Rubenstrunk France	4	319 1.2×	178 0.7×	338 1.4×	89 0.6×	55 0.6×	7	625
Daniel Jahn Germany	17	314 1.2×	144 0.6×	418 1.7×	98 0.7×	77 0.8×	24	796
Lay T. Gan Australia	4	529 2.0×	205 0.9×	170 0.7×	99 0.7×	98 1.0×	5	668
Mulugeta Seneshaw United States	8	500 1.9×	194 0.8×	237 1.0×	96 0.7×	110 1.1×	16	720
Gemma Òdena Spain	11	414 1.6×	122 0.5×	194 0.8×	67 0.5×	66 0.7×	23	710
Jacqueline Williams Australia	8	377 1.4×	142 0.6×	142 0.6×	64 0.4×	76 0.8×	8	475
Binxia Chang China	11	413 1.5×	118 0.5×	133 0.6×	61 0.4×	59 0.6×	21	658
Monique Allman United States	6	566 2.1×	166 0.7×	243 1.0×	88 0.6×	59 0.6×	6	707
Fernando Javier Barreyro Argentina	10	564 2.1×	138 0.6×	284 1.2×	139 1.0×	167 1.7×	25	876
Akitoshi Douhara Japan	14	353 1.3×	143 0.6×	154 0.6×	125 0.9×	32 0.3×	25	653

Countries citing papers authored by Noriko Shimazu

Since Specialization

Citations

This map shows the geographic impact of Noriko Shimazu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Shimazu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Shimazu more than expected).

Fields of papers citing papers by Noriko Shimazu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Shimazu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Shimazu. The network helps show where Noriko Shimazu may publish in the future.

Co-authorship network of co-authors of Noriko Shimazu

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Shimazu. A scholar is included among the top collaborators of Noriko Shimazu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Shimazu. Noriko Shimazu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shiba, Kumiko, Kyoichiro Tsuchiya, Chikara Komiya, et al.. (2018). Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. Scientific Reports. 8(1). 2362–2362. 132 indexed citations

Komiya, Chikara, Miyako Tanaka, Kyoichiro Tsuchiya, et al.. (2017). Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis. Scientific Reports. 7(1). 44754–44754. 49 indexed citations

Miyachi, Yasutaka, Kyoichiro Tsuchiya, Chikara Komiya, et al.. (2017). Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glucose Intolerance. Cell Reports. 18(11). 2766–2779. 52 indexed citations

Komiya, Chikara, Kyoichiro Tsuchiya, Kumiko Shiba, et al.. (2016). Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PLoS ONE. 11(3). e0151511–e0151511. 186 indexed citations

Saito, Kota, et al.. (2014). Concentration of Sec12 at ER exit sites via interaction with cTAGE5 is required for collagen export. The Journal of Cell Biology. 206(6). 751–762. 81 indexed citations

Fujimura, Hisako, et al.. (2007). Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. Experimental and Toxicologic Pathology. 58(6). 375–382. 31 indexed citations

Hasegawa, Takafumi, Noriko Shimazu, T. Inomata, et al.. (1999). Evaluation of Risk and Benefit of Oral Immunomodulation using Heat-killed Enterococcus Faecalis FK-23 Preparation in Healthy Dogs. International Journal of Immunopathology and Pharmacology. 12(2). 81–87. 3 indexed citations

Matsubara, Shigeki, et al.. (1995). Importance of Impairment of the Airway Epithelium for Ozone-Induced Airway Hyperresponsiveness in Guinea Pigs. The Japanese Journal of Pharmacology. 67(4). 375–382. 17 indexed citations

Doi, Kazuteru, et al.. (1991). Systemic histopathology of rats with CCl₄-induced hepatic cirrhosis. Laboratory Animals. 25(1). 21–25. 43 indexed citations

10.

Fukuoka, Hiroshi, Takehiro Takagi, Noriko Shimazu, & Hiroyuki Nagai. (1986). [Tuberous sclerosis with intraventricular tumor: report of 2 cases].. PubMed. 14(11). 1377–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact